Insider & Institutional Ownership
15.6% of Leafly shares are held by institutional investors. Comparatively, 13.4% of iCoreConnect shares are held by institutional investors. 6.9% of Leafly shares are held by company insiders. Comparatively, 59.4% of iCoreConnect shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Leafly and iCoreConnect”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Leafly | $35.87 million | 3.24 | -$9.50 million | ($1.60) | -23.13 |
| iCoreConnect | $11.05 million | 0.00 | -$15.55 million | ($44.40) | 0.00 |
Profitability
This table compares Leafly and iCoreConnect’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Leafly | -14.65% | N/A | -25.26% |
| iCoreConnect | -263.12% | -1,451.73% | -171.32% |
Volatility and Risk
Leafly has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, iCoreConnect has a beta of 32.08, meaning that its share price is 3,108% more volatile than the S&P 500.
Summary
Leafly beats iCoreConnect on 8 of the 11 factors compared between the two stocks.
About Leafly
Leafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. The company offers subscription-based marketplace listings, digital advertising solutions, and software as a service-based tools to cannabis retailers; and information, reviews, menus, and ordering and delivery options to its audience through its website and mobile applications. Leafly Holdings, Inc. was founded in 2010 and is headquartered in Seattle, Washington.
About iCoreConnect
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.
Receive News & Ratings for Leafly Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leafly and related companies with MarketBeat.com's FREE daily email newsletter.
